Increased Diabetes Prevalence Due to Medical Advances
|
By HospiMedica International staff writers Posted on 17 May 2016 |
A new study has concluded that the global increase in type 1 diabetes (T1D) mellitus is directly linked to reduced natural selection resulting from improved medical care.
Researchers at the University of Adelaide (UA; Australia) and the University of Zurich (UZH; Switzerland) examined the prevalence of T1D in 118 countries and concurrent changes in life expectancy from 1950 to 2010 to test correlation of T1D to reduced natural selection, as measured by the Biological State Index. To do so, they first obtain country-specific estimates of T1D prevalence, life expectancy, obesity prevalence rate, urbanization rates, per capita sugars consumption, and per capita gross domestic product (GDP).
The data obtained were then matched to T1D prevalence in all the countries, which were also grouped to study associations in different geographical regions. After applying the Biological State Index to the data, they found that the rapid worldwide increase in T1D over the last few decades was directly linked with increases in human life expectancy, especially in Western countries, and therefore a reduction in natural selection. The study was published on March 2, 2106, in BMJ Open Diabetes Research & Care.
“The current prevailing paradigm on the increasing prevalence of T1D is that environmental pressures are now able to trigger genotypes. Currently, medical gene intervention in modern medicine at this stage cannot remove T1D genes, and eugenics can offer no direction due to ethics issue,” concluded study co-author Wen-Peng You, PhD, of UA. “Study of T1D epidemiology based on prevalence/incidence T1D data of all age groups has become imperative, as it may offer optimal solution to address, or at least slow down, T1D genetic load increases in different populations.”
“Natural selection is one of the major evolutionary forces that inform changes in our genes, across populations and over generations. This is the first major disease we have shown that is accumulating due to a relaxation of natural selection over time,” said study co-author Professor Maciej Henneberg, PhD, of UA and UZH. “It's unlikely this situation will ever be reversed, meaning that in order to overcome the problems associated with type 1 diabetes for our population, some form of gene therapy to repair the faulty genes may need to be considered.”
Natural selection, one of the basic mechanisms of evolution, is the differential survival and fertility of individuals due to differences in phenotype that reflect genetic differences. In modern society, natural selection still acts on all members of a population, selecting those that have an increased reproductive success due to survival and/or fertility. The Biological State Index takes into account potential loss of reproductive success by dying at an earlier age. The effect of natural selection on contemporary populations is declining due to modern medicine.
Related Links:
University of Adelaide
University of Zurich
Researchers at the University of Adelaide (UA; Australia) and the University of Zurich (UZH; Switzerland) examined the prevalence of T1D in 118 countries and concurrent changes in life expectancy from 1950 to 2010 to test correlation of T1D to reduced natural selection, as measured by the Biological State Index. To do so, they first obtain country-specific estimates of T1D prevalence, life expectancy, obesity prevalence rate, urbanization rates, per capita sugars consumption, and per capita gross domestic product (GDP).
The data obtained were then matched to T1D prevalence in all the countries, which were also grouped to study associations in different geographical regions. After applying the Biological State Index to the data, they found that the rapid worldwide increase in T1D over the last few decades was directly linked with increases in human life expectancy, especially in Western countries, and therefore a reduction in natural selection. The study was published on March 2, 2106, in BMJ Open Diabetes Research & Care.
“The current prevailing paradigm on the increasing prevalence of T1D is that environmental pressures are now able to trigger genotypes. Currently, medical gene intervention in modern medicine at this stage cannot remove T1D genes, and eugenics can offer no direction due to ethics issue,” concluded study co-author Wen-Peng You, PhD, of UA. “Study of T1D epidemiology based on prevalence/incidence T1D data of all age groups has become imperative, as it may offer optimal solution to address, or at least slow down, T1D genetic load increases in different populations.”
“Natural selection is one of the major evolutionary forces that inform changes in our genes, across populations and over generations. This is the first major disease we have shown that is accumulating due to a relaxation of natural selection over time,” said study co-author Professor Maciej Henneberg, PhD, of UA and UZH. “It's unlikely this situation will ever be reversed, meaning that in order to overcome the problems associated with type 1 diabetes for our population, some form of gene therapy to repair the faulty genes may need to be considered.”
Natural selection, one of the basic mechanisms of evolution, is the differential survival and fertility of individuals due to differences in phenotype that reflect genetic differences. In modern society, natural selection still acts on all members of a population, selecting those that have an increased reproductive success due to survival and/or fertility. The Biological State Index takes into account potential loss of reproductive success by dying at an earlier age. The effect of natural selection on contemporary populations is declining due to modern medicine.
Related Links:
University of Adelaide
University of Zurich
Latest Critical Care News
- Tiny Sensor to Transform Head Injury Detection
- Bacterial Behavior Breakthrough to Improve Infection Prevention in Biomedical Devices
- Implanted 'Living Skin' Indicates Internal Inflammation Without Blood Samples
- AI Tool Improves Speed and Accuracy of Cervical Cancer Treatment Planning
- Ultrasonic Sensor Enables Cuffless and Non-Invasive Blood Pressure Measurement
- Simple Change in Sepsis Treatment Could Save Thousands of Lives
- AI-Powered ECG Analysis Enables Early COPD Detection
- Soft Wireless Implant Treats Inflammatory Bowel Disease
- Pill Reports from Stomach When It Has Been Swallowed
- Wireless Sensing Technology Enables Touch-Free Diagnostics of Common Lung Diseases
- Early Detection and Targeted Blood Purification Could Prevent Kidney Failure in ICU Patients
- New Cancer Treatment Uses Sound-Responsive Particles to Soften Tumors
- Sprayable Powder-Type Hemostatic Agent Stops Bleeding in One Second
- Ultra-Stable Mucus-Inspired Hydrogel Boosts Gastrointestinal Wound Healing
- AI Model Helps Diagnose Often Undetected Heart Disease from Simple EKG
- E-Tattoos Harvest Energy and Monitor Health in Real Time
Channels
Surgical Techniques
view channel
Minimally Invasive Coronary Artery Bypass Method Offers Safer Alternative to Open-Heart Surgery
Coronary artery obstruction is a rare but often fatal complication of heart-valve replacement, particularly in patients with complex anatomy or prior cardiac interventions. In such cases, traditional open-heart... Read more
Injectable Breast ‘Implant’ Offers Alternative to Traditional Surgeries
Breast cancer surgery can require the removal of part or all of the breast, leaving patients with difficult decisions about reconstruction. Current reconstructive options often rely on prosthetic implants... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
B. Braun Acquires Digital Microsurgery Company True Digital Surgery
The high-end microsurgery market in neurosurgery, spine, and ENT is undergoing a significant transformation. Traditional analog microscopes are giving way to digital exoscopes, which provide improved visualization,... Read more
CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is scheduled to be held from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) in Guangzhou.... Read more







